Major Article - BIT225, in combination with 3-drug antiretroviral therapy, page-132

Please enlighten us seriously can you share your knowledge with out being such a superior being.

Latest paper was important
BIT225 compound tested with Atripla I'm guessing BIT just didn't pull any drug out of a hat.
Is this one of the hoops Biotron is being made to jump through for partnership.
Atripla is gilead

I was also interested in Anchalee Avihingsanon credited on our paper as she has ties to Gilead.

Anchalee Avihingsanonalso just presented an abstract for Gilead at the APACC 2020
P_03 Poster Efficacy and Safety of Switching to B/F/TAF in Virologically
Suppressed Asian Adults Living with HIV
Anchalee
Avihingsanon
Thailand





Gilead Sciences, Inc. on 9 Oct 2020 announced that four abstracts have been selected for poster presentations at the virtual
2020 Asia Pacific AIDS & Co-infections Conference (APACC) being held from October 15-17, 2020.


https://www.gilead.com/news-and-press/press-room/press-releases/2020/10/gilead-presents-new-data-from-antiviral-development-programs-at-idweek-2020

Why was Biotron not represented at this conference it our part of the world and considering the paper we just released should have been involved?

So yes was wondering about Gileads patents with BIT225.

Its a open forum for all people not just for the gods that walk among us. Put me on ignore.